Drug Discovery Solutions

31. Cell-Based Assay Development And Testing 5/28/2026

    Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.

32. Structural Biology Services 5/28/2026

    At Curia, our team of expert protein chemists and structural biologists brings the advanced experience and technology needed to support all your structural biology services needs.

33. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

34. Hybridoma Services 6/5/2026

    Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.

35. Discover Our iPSC Differentiated Cell Services 9/30/2025

    iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.

36. Biologics Discovery 5/28/2026

    Make the most of your molecule with integrated antibody discovery, engineering, and production capabilities designed to accelerate lead identification and optimization.

37. Antibody Developability Analysis 6/5/2026

    Evaluating the developability of therapeutic drug candidates early can help circumvent potential issues in late-stage development.

38. NanoAssemblr® Spark™: Freedom To Discover 4/14/2022

    The NanoAssemblr^® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.

39. Accelerating CHO Bulk Harvest Testing Requires Rapid Methods 1/14/2026

    Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.

40. Expediting Drug Discovery From Concept To Commercialization 8/13/2024

    Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.